Table 2.
Clinical characteristics of OP patients
| No. | Age | Sex | Dose (Gy/4 fr*) |
Toxicity grade (CTCAE ver4) |
CRP (IU/ml) | KL-6 (U/ml)† | Treatment after first OP | ||
|---|---|---|---|---|---|---|---|---|---|
| Dyspnea | Fever | Fatigue | |||||||
|
1 |
62 |
M |
52 |
2 |
|
2 |
5.7 |
813 |
|
|
2 |
80 |
M |
48 |
2 |
|
3 |
0.9 |
456 |
|
|
3 |
79 |
M |
48 |
3 |
1 |
2 |
22.7 |
558 |
PSL** + Abx†† |
|
4 |
71 |
F |
52 |
2 |
1 |
2 |
4.0 |
299 |
Abx |
|
5 |
76 |
M |
52 |
2 |
|
2 |
1.1 |
414 |
PSL |
|
6 |
82 |
M |
52 |
3 |
2 |
3 |
21.0 |
653 |
PSL + Abx |
|
7 |
83 |
M |
52 |
3 |
2 |
3 |
10.6 |
231 |
Abx |
|
8 |
79 |
M |
50 |
3 |
2 |
3 |
5.8 |
531 |
PSL + Abx |
| 9 | 83 | F | 50 | 3 | 3 | 5.9 | 314 | PSL + Abx | |
*fr = fractions. **PSL = Prednisone. ††Abx = antibiotics.
† Normal range for KL-6 is ≤ 500 U/ml in the institutions.
CRP and KL-6 data represent the maximum level during the initial OP course. Relapse of OP occurred in patients No. 6-9.